Opening Remarks from Dr. Herzog, Dr. Krivak, and Dr. Hagemann

Thomas Herzog, MD, Thomas Krivak, MD, and Ian Hagemann, MD, PhD open their discussion by introducing themselves and the objectives of the program.

Related Keywords

Thomas Herzog ,Kian Hagemann ,Thomas Krivak , ,Optimizing Homologous Recombination Deficiency ,Testing Paradigms ,Ovarian Cancer ,